Conversely, by increasing ROCK1 expression, strontium ranelate (SrR, an anti-osteoporosis drug) promotes the osteogenesis of ovariectomy rat bone marrow mesenchymal stem cells (OVX-rBMSCs) and cell viability of primary osteoblasts [64]. The gene discussed is ROCK1; the disease is osteoporosis.